Furthermore, median biomarkers of inflammation (ALT, AST, and CRP) were significantly lower in patients with SARS-CoV-2 + rhinovirus co-infection in comparison to patients with SARS-CoV-2 mono-infection. This evidence concerns the gene CRP and infection.